. Prolactin inhibitor that acts by direct stimulation of the D2-dopamine receptors on pituitary lactotrophs, thus inhibiting prolactin secretion.


. Has a potent and long-lasting prolactin-lowering activity.


. Indicated for inhibition/suppression of physiological lactation & treatment of hyperprolactinaemic disorders.

. 84% of patients had normal serum prolactin levels after cabergoline treatment at doses 1 – 2 mg/ week.


. 90% showing disappearance of Galactorrhea.


. 50 – 90% reduction in tumor size in female and male patients with micro- or macroprolactinoma.

Additional information


Men health care

There are no reviews yet.

Be the first to review “ELONDA”

Your email address will not be published.